Innovasis seeks US ok for cervical plate:
This article was originally published in Clinica
US spinal implant firm Innovasis has submitted to the US FDA a 510(k) marketing application for its cervical plate system. OpteryX is a cervical plate with a self-locking mechanism with features that include: no-step locking, one to four level plates, and apertures for easy graft visualisation with variable, fixed and self-tapping screws. The Salt Lake City, Utah firm said it expected to gain US market clearance for the product in the second half of 2006.
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.